Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.

ABSTRACT:

Objectives

Different studies have been conducted on the role of curcumin in health since having multiple properties, including antioxidant and anti-inflammatory effects. Due to the lack of studies regarding curcumin effects on obese patients with non-alcoholic fatty liver disease (NAFLD), our protocol was designed to assess nanocurcumin impacts on blood sugar, lipids, inflammatory indices, insulin resistance and liver function, especially by nesfatin.

Setting

This trial will be conducted in the Oil Company central hospital of Tehran, Iran with a primary level of care.

Participants

84 obese patients with NAFLD diagnosed using ultrasonography will be employed according to the eligibility criteria‎.

Interventions

The patients will be randomly divided into two equa

SUBMITTER: Jazayeri-Tehrani SA 

PROVIDER: S-EPMC5726126 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature